Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1235.00
-10.50 (-0.84%)
< Home < Back

Dr. Reddys Laboratories informs about press release

Date: 17-09-2020

Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 17th September 2020 titled ‘Dr. Reddy’s announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalent of Pataday®, the Eye Allergy Drop in the U.S. Market’.

The above information is a part of company’s filings submitted to BSE.